Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Surgical prophylaxis: the evolution of guidelines in an era of cost containment.

Akalin HE.

J Hosp Infect. 2002 Jan;50 Suppl A:S3-7. Review.

PMID:
11993641
2.

The place of antibiotic therapy in the management of chronic acute exacerbations of chronic bronchitis.

Akalin HE.

Int J Antimicrob Agents. 2001;18 Suppl 1:S49-55. Review.

PMID:
11574196
3.

A retrospective review of 228 episodes of infective endocarditis where rheumatic valvular disease is still common.

Cetinkaya Y, Akova M, Akalin HE, Aşçioğlu S, Hayran M, Uzuns O, Aksöyek S, Tokgözoğlu L, Oto A, Kes S, Paşaoğlu I, Unal S.

Int J Antimicrob Agents. 2001 Jul;18(1):1-7.

PMID:
11463520
4.

Risk factors influencing clinical outcome in Staphylococcus aureus bacteraemia in a Turkish University Hospital.

Topeli A, Unal S, Akalin HE.

Int J Antimicrob Agents. 2000 Feb;14(1):57-63.

PMID:
10717502
5.

Quinolones in the treatment of typhoid fever.

Akalin HE.

Drugs. 1999;58 Suppl 2:52-4. Review.

PMID:
10553706
6.

The role of beta-lactam/beta-lactamase inhibitors in the management of mixed infections.

Akalin HE.

Int J Antimicrob Agents. 1999 Aug;12 Suppl 1:S15-20; discussion S26-7. Review.

PMID:
10526869
7.

In vitro activities of antibiotics alone and in combination against Brucella melitensis at neutral and acidic pHs.

Akova M, Gür D, Livermore DM, Kocagöz T, Akalin HE.

Antimicrob Agents Chemother. 1999 May;43(5):1298-300.

8.

Septic shock as a predictor of mortality in bacteremia caused by coagulase-negative staphylococci.

Topeli A, Unal S, Hayran M, Akalin HE.

Eur J Clin Microbiol Infect Dis. 1997 Jun;16(6):411-6.

PMID:
9248743
9.

Treatment of enteric fever with pefloxacin for 7 days versus 5 days: a randomized clinical trial.

Unal S, Hayran M, Tuncer S, Gür D, Uzun O, Akova M, Akalin HE.

Antimicrob Agents Chemother. 1996 Dec;40(12):2898-900.

10.

Efficacy of sulbactam-ampicillin for the treatment of severe diabetic foot infections.

Akova M, Ozcebe O, Güllü I, Unal S, Gür D, Akalin S, Tokgözoglu M, Telatar F, Akalin HE.

J Chemother. 1996 Aug;8(4):284-9.

PMID:
8873834
11.

Clinical implications of aminopenicillins with beta-lactamase inhibitors.

Akalin HE.

Int J Antimicrob Agents. 1996 Jun;7 Suppl 1:S15-9.

PMID:
18611774
12.

Resistance patterns in Turkey.

Gür D, Unal S, Akalin HE.

Int J Antimicrob Agents. 1995 Sep;6(1):23-6.

PMID:
18611680
13.

Transferable production of PER-1 beta-lactamase in Pseudomonas aeruginosa.

Danel F, Hall LM, Gur D, Akalin HE, Livermore DM.

J Antimicrob Chemother. 1995 Feb;35(2):281-94.

PMID:
7759392
14.

Role of quinolones in the treatment of diarrhoeal diseases.

Akalin HE.

Drugs. 1995;49 Suppl 2:128-31. Review.

PMID:
8549281
15.

Penicillin resistance in Streptococcus pneumoniae in Turkey.

Gür D, Tunçkanat F, Sener B, Kanra G, Akalin HE.

Eur J Clin Microbiol Infect Dis. 1994 May;13(5):440-1. No abstract available.

PMID:
8070464
16.

Efficacy of fluconazole in the treatment of upper gastrointestinal candidiasis in neutropenic patients with cancer: factors influencing the outcome.

Akova M, Akalin HE, Uzun O, Hayran M, Tekuzman G, Kansu E, Aslan S, Telatar H.

Clin Infect Dis. 1994 Mar;18(3):298-304.

PMID:
8011807
17.
18.

Atypical pneumonias: therapeutic possibilities.

Akalin HE.

Int J Antimicrob Agents. 1993 Nov;3 Suppl 1:S75-9.

PMID:
18611582
19.

Quinolones in treatment of human brucellosis: comparative trial of ofloxacin-rifampin versus doxycycline-rifampin.

Akova M, Uzun O, Akalin HE, Hayran M, Unal S, Gür D.

Antimicrob Agents Chemother. 1993 Sep;37(9):1831-4.

20.

OXA-11, an extended-spectrum variant of OXA-10 (PSE-2) beta-lactamase from Pseudomonas aeruginosa.

Hall LM, Livermore DM, Gur D, Akova M, Akalin HE.

Antimicrob Agents Chemother. 1993 Aug;37(8):1637-44.

21.

Treatment of intracranial abscesses: experience with sulbactam/ampicillin.

Akova M, Akalìn HE, Korten V, Ozgen T, Erbengi A.

J Chemother. 1993 Jun;5(3):181-5.

PMID:
8371128
22.

Spontaneous peritonitis due to Brucella melitensis in a patient with cirrhosis.

Demirkan F, Akalin HE, Simşek H, Ozyilkan E, Telatar H.

Eur J Clin Microbiol Infect Dis. 1993 Jan;12(1):66-7. No abstract available.

PMID:
8462568
23.

Quinolones in the treatment of acute bacterial diarrhoeal diseases.

Akalin HE.

Drugs. 1993;45 Suppl 3:114-8. Review.

PMID:
7689441
24.
25.

[Penicillin resistance in Streptococcus pneumoniae strains].

Tunçkanat F, Akan O, Gür D, Akalin HE.

Mikrobiyol Bul. 1992 Oct;26(4):307-13. Turkish. Erratum in: Mikrobiyol Bul 1993 Jan;27(1):92.

PMID:
1435360
26.

Diversity of klebsiellae with extended-spectrum beta-lactamases at a Turkish university hospital.

Gür D, Pitt TL, Hall LM, Akalin HE, Livermore DM.

J Hosp Infect. 1992 Oct;22(2):163-7. No abstract available.

PMID:
1358959
27.

[In vitro activity of various antibiotic agents against gram-negative nosocomial bacteremia pathogens].

Gür D, Kocagöz T, Akalin HE.

Mikrobiyol Bul. 1992 Jul;26(3):233-41. Turkish.

PMID:
1528143
28.
29.

Long-term oral ciprofloxacin in the treatment of prosthetic valve endocarditis due to Pseudomonas aeruginosa.

Uzun O, Akalin HE, Unal S, Demircin M, Yorgancioglu AC, Ugurlu B.

Scand J Infect Dis. 1992;24(6):797-800.

PMID:
1287815
30.

Emergence of Candida krusei infections after therapy of oropharyngeal candidiasis with fluconazole.

Akova M, Akalin HE, Uzun O, Gür D.

Eur J Clin Microbiol Infect Dis. 1991 Jul;10(7):598-9. No abstract available.

PMID:
1915408
31.

[In vitro susceptibility of Campylobacter jejuni and Campylobacter coli to quinolone antibiotics].

Gür D, Hasçelik G, Akyön Y, Akalin HE, Diker S.

Mikrobiyol Bul. 1989 Jul;23(3):185-9. Turkish.

PMID:
2518646
32.

[In vitro antibiotic susceptibility of staphylococci].

Baykal M, Akalin HE.

Mikrobiyol Bul. 1989 Apr;23(2):157-62. Turkish.

PMID:
2626105
33.
34.

Aminoglycoside resistance patterns in Turkey.

Akalin HE, Torun M, Alacam R.

Scand J Infect Dis. 1988;20(2):199-203.

PMID:
2840733
35.

Serum bactericidal and opsonic activities in patients with non-alcoholic cirrhosis.

Akalin HE, Laleli Y, Telatar H.

Q J Med. 1985 Aug;56(220):431-7.

PMID:
3901076
36.

Bactericidal activity of ascitic fluid in patients with nephrotic syndrome.

Akalin HE, Fisher KA, Laleli Y, Caglar S.

Eur J Clin Invest. 1985 Jun;15(3):138-40.

PMID:
3926507
37.

Comparison of enzyme-mediated aminoglycoside resistance in gram-negative bacilli isolated in Turkey and the United States.

Akalin HE, Lolans V.

J Infect Dis. 1983 Dec;148(6):1128. No abstract available.

PMID:
6317771
38.

Bactericidal and opsonic activity of ascitic fluid from cirrhotic and noncirrhotic patients.

Akalin HE, Laleli Y, Telatar H.

J Infect Dis. 1983 Jun;147(6):1011-7.

PMID:
6854061
39.

Fc rosette inhibition by serum of patients with infective endocarditis.

Akalin HE, Bakkaloğlu A.

Scand J Infect Dis. 1981;13(1):37-9.

PMID:
7244557
40.
41.

[Drug fever due to isoniazid].

Akalin HE, Artvinli M, Aslan S.

Mikrobiyol Bul. 1979 Jan;13(1):101-5. Turkish.

PMID:
555786
42.

Actinobacillus actinomycetemcomitans endocarditis in a patient with a prosthetic aortic valve.

Panwalker AP, Akalin HE, Zimelis V, Jackson GG.

Infection. 1977;5(2):104-6.

PMID:
881258
43.

Inflammatory lesions localized with technetium Tc 99m-labeled leukocytes.

Andersen BR, English D, Akalin HE, Henderson W.

Arch Intern Med. 1975 Aug;135(8):1067-71.

PMID:
1156068

Supplemental Content

Loading ...
Support Center